Spain Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Spanish pharmaceuticals market had total revenues of $26.5 billion in 2022, representing a compound annual growth rate (CAGR) of 14.3% between 2017 and 2022.
0
According to in-house research, in 2022, Spain accounted for 7.5% of the European pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in Spain stood at 14.6% of total health spending in 2021.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Spain
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Spain
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Spain pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the Spain pharmaceuticals market by value in 2022?
What will be the size of the Spain pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the Spain pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in Spain's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What strategies do leading players follow?

8 Company Profiles

8.1. Almirall S.A.
8.2. GSK plc.
8.3. AstraZeneca PLC

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Spain pharmaceuticals market value: $ billion, 2017-22
Table 2: Spain pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Spain pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Almirall S.A.: key facts
Table 5: Almirall S.A.: Annual Financial Ratios
Table 6: Almirall S.A.: Key Employees
Table 7: GSK plc.: key facts
Table 8: GSK plc.: Annual Financial Ratios
Table 9: GSK plc.: Key Employees
Table 10: GSK plc.: Key Employees Continued
Table 11: AstraZeneca PLC: key facts
Table 12: AstraZeneca PLC: Annual Financial Ratios
Table 13: AstraZeneca PLC: Key Employees
Table 14: AstraZeneca PLC: Key Employees Continued
Table 15: Spain size of population (million), 2018-22
Table 16: Spain gdp (constant 2005 prices, $ billion), 2018-22
Table 17: Spain gdp (current prices, $ billion), 2018-22
Table 18: Spain inflation, 2018-22
Table 19: Spain consumer price index (absolute), 2018-22
Table 20: Spain exchange rate, 2018-22

List of Figures

Figure 1: Spain pharmaceuticals market value: $ billion, 2017-22
Figure 2: Spain pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Spain pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Spain, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Spain, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Spain, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Almirall S.A.
GSK plc.
AstraZeneca PLC

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€338EUR$350USD£281GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€507EUR$525USD£421GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€676EUR$700USD£561GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Global Market Report 2024

Generic Pharmaceuticals Global Market Report 2024

Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2024-2032

The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide

Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Forecast 2024-2030